In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela. The drug's maker, however, claims that it remains safe and effective.

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.

The drug has been associated with severe side effects such as seizures and muscle control loss, with over 3,600 adverse health reactions reported.

Dangerous side effects from the injectable canine drug Librela — used to treat osteoarthritis joint pain — have been linked to seizures, lameness and loss of muscle control, the FDA warned.

The warning was issued for Librela, which is a painkiller commonly given to dogs to relieve arthritis pain. The drug is administered by a vet once a month via subcutaneous injection. The FDA has said that dogs on Librela may experience dangerous side effects, such as: Seizures. Loss of muscle control . Urinary incontinence. Death.

(WDBJ) - The U.S. Food and Drug Administration has issued an alert to veterinarians about a popular medication used to control pain associated with osteoarthritis in dogs after numerous reports of adverse side effects and death.